Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

Author： Gaist David   García Rodríguez Luis Alberto   Huerta Consuelo   Hallas Jesper   Sindrup Søren H.  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.56, Iss.12, 2001-03, pp. : 931-933

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New prospects for lipid-lowering drugs

By Thompson G.R.   Naoumova R.P.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 715-727

Informa Healthcare

Access to resources Recommend Favorite

Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells

By Genvigir Fabiana Dalla Vecchia   Rodrigues Alice Cristina   Cerda Alvaro   Arazi Simone Sorkin   Willrich Maria Alice Vieira   Oliveira Raquel   Hirata Mario Hiroyuki   Dorea Egidio Lima   Bernik Márcia Martins   Curi Rui   Hirata Rosario Dominguez Crespo  

Pharmacogenomics, Vol. 11, Iss. 9, 2010-09 ,pp. : 1235-1246

Future Medicine

Access to resources Recommend Favorite

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K   Evans Jeffery D  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Patients are less likely to receive lipid-lowering drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A New Class of Lipid-Lowering Drugs: Ezetimibe

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 214-216

Karger

Access to resources Recommend Favorite